Obgyn · Year 3 · from Obgyn
Case 3: Advanced Maternal Age Counseling
Patient Demographics
- Age: 38 years
- Sex: Female
- Occupation: Attorney
Chief Complaint
"I'm 10 weeks pregnant and worried about my age affecting the baby."
History of Present Illness
The patient presents for her first prenatal visit at 10 weeks gestation confirmed by LMP and early ultrasound. She conceived spontaneously after 4 months of trying. She is concerned about the risks associated with her age, particularly Down syndrome. She has mild fatigue but no significant pregnancy symptoms. Her sister has a child with a chromosomal abnormality.
Past Medical History
- Well-controlled hypertension on labetalol 100 mg twice daily
- No diabetes
- No prior surgeries
Obstetric History
- G2P1001 (one prior term vaginal delivery at age 32, healthy child)
Physical Examination Findings
- Vital Signs: BP 128/78 mmHg, HR 72 bpm, BMI 27 kg/m2
- General: Well-appearing female
- Cardiovascular: Regular rate and rhythm
- Abdomen: Soft, gravid uterus palpable at symphysis
- Pelvic: Cervix closed, uterus 10-week size
Diagnostic Discussion
Age-Related Risks:
- At age 38, the risk of trisomy 21 is approximately 1 in 175 (compared to 1 in 1,250 at age 25)
- Risk of any chromosomal abnormality is approximately 1 in 85
- Additional risks include gestational diabetes, preeclampsia, cesarean delivery, and stillbirth
Screening Options Discussed:
- Cell-free DNA (cfDNA) screening: >99% detection rate for trisomy 21, low false positive rate; can be done now at 10 weeks
- First-trimester combined screening: Nuchal translucency + serum markers at 11-14 weeks; ~85% detection rate
- Diagnostic testing: Chorionic villus sampling (CVS) at 10-13 weeks or amniocentesis at 15-20 weeks provides definitive diagnosis
Diagnosis
Intrauterine Pregnancy at 10 weeks in woman of Advanced Maternal Age (AMA)
- Chronic hypertension in pregnancy
Management Plan
Genetic Counseling:
- Patient elects cell-free DNA screening given high detection rate
- Will consider CVS if cfDNA is positive or inconclusive
- Detailed anatomy ultrasound at 18-22 weeks regardless of screening results
Hypertension Management:
- Continue labetalol (safe in pregnancy)
- Monitor blood pressure at each visit
- 24-hour urine protein at baseline
- Early screening for preeclampsia development
AMA-Specific Surveillance:
- Earlier glucose screening consideration (given AMA and obesity)
- Serial growth ultrasounds in third trimester
- Antenatal testing starting at 36-37 weeks
- Discussion of delivery timing (typically by 39-40 weeks)
Counseling Points:
- cfDNA is a screening test, not diagnostic - positive results require confirmation
- Most women with advanced maternal age have healthy pregnancies
- Close monitoring will help identify and manage any complications early
- Low-dose aspirin 81 mg daily starting at 12 weeks for preeclampsia prevention (multiple risk factors)
Prognosis
With appropriate prenatal care and surveillance, the likelihood of a healthy pregnancy outcome remains high. The patient's chronic hypertension will require close monitoring for superimposed preeclampsia.